BioCentury
ARTICLE | Clinical News

Veregen sinecatechins regulatory update

September 16, 2013 7:00 AM UTC

Medigene said Canada approved Veregen sinecatechins to treat genital warts. Medigene said Canadian partner Triton is expected to launch the product in the country next half. The topical formulation of polyphenols extracted from green tea leaves is marketed in the U.S., Germany, Austria, Spain, Switzerland, Serbia and the Netherlands. ...